1,270
Views
76
CrossRef citations to date
0
Altmetric
Perspective

Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control

Pages 3389-3394 | Received 22 Jun 2012, Accepted 06 Jul 2012, Published online: 23 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Thomas Neill, Liliana Schaefer & Renato V Iozzo. (2015) Oncosuppressive functions of decorin . Molecular & Cellular Oncology 2:3.
Read now
P Fernández-Martínez, C Zahonero & P Sánchez-Gómez. (2015) DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis. Molecular & Cellular Oncology 2:1.
Read now
Ulf Soppa, Julian Schumacher, Victoria Florencio Ortiz, Tobias Pasqualon, Francisco Tejedor & Walter Becker. (2014) The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1 and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle 13:13, pages 2084-2100.
Read now

Articles from other publishers (72)

KyeongJin Kim & Sang Bae Lee. (2023) Regulation of CMGC kinases by hypoxia. BMB Reports 56:11, pages 584-593.
Crossref
Dipti Patil & Lokesh Kumar Bhatt. (2023) Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy. American Journal of Cardiovascular Drugs 23:6, pages 623-640.
Crossref
Yuta Mochimaru & Kiyotsugu Yoshida. (2023) Functional Roles of DYRK2 as a Tumor Regulator. Current Issues in Molecular Biology 45:10, pages 8539-8551.
Crossref
Elizabeth K. J. Hogg & Greg M. Findlay. (2023) Functions of SRPK , CLK and DYRK kinases in stem cells, development, and human developmental disorders . FEBS Letters.
Crossref
Rong Qiao, Qiang Zhu, Feifei Di, Chunlan Liu, Yakang Song, Jin Zhang, Tian Xu, Yue Wang, Liping Dai, Wanjian Gu, Baohui Han & Rongxi Yang. (2023) Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk . Molecular Carcinogenesis.
Crossref
James W. Bruce, Eunju Park, Chris Magnano, Mark Horswill, Alicia Richards, Gregory Potts, Alexander Hebert, Nafisah Islam, Joshua J. Coon, Anthony Gitter, Nathan Sherer & Paul Ahlquist. (2023) HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B. PLOS Pathogens 19:7, pages e1011492.
Crossref
Saishu Yoshida & Kiyotsugu Yoshida. (2023) New insights into the roles for DYRK family in mammalian development and congenital diseases. Genes & Diseases 10:3, pages 758-770.
Crossref
Liat Stoler-Barak, Ethan Harris, Ayelet Peres, Hadas Hezroni, Mirela Kuka, Pietro Di Lucia, Amalie Grenov, Neta Gurwicz, Meital Kupervaser, Bon Ham Yip, Matteo Iannacone, Gur Yaari, John D. Crispino & Ziv Shulman. (2023) B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation. Nature Communications 14:1.
Crossref
Xiuke Ouyang, Zhuqing Wang, Bingtong Wu, Xiuxia Yang & Bo Dong. (2023) The Conserved Transcriptional Activation Activity Identified in Dual-Specificity Tyrosine-(Y)-Phosphorylation-Regulated Kinase 1. Biomolecules 13:2, pages 283.
Crossref
Jiaxin Zhao, Yanyan Xu, Jiqiu Wang, Junling Liu, Ruiyan Zhang & Xiaoxiang Yan. (2022) Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production. Thrombosis and Haemostasis 123:02, pages 192-206.
Crossref
Trevor G. Shepherd & Frederick A. Dick. (2022) Principles of dormancy evident in high-grade serous ovarian cancer. Cell Division 17:1.
Crossref
Jiawei Tang, Youquan Xie, Jingxun Huang, Liao Zhang, Weiye Jiang, Zhiyu Li & Jinlei Bian. (2022) A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing. Bioorganic & Medicinal Chemistry 70, pages 116921.
Crossref
Shanshan Zeng, Meifeng Li, Xining Cheng, Shina Lu, Zhiqing Feng, Zeyin Jiang, Zhichao Sun, Xiaowen Xu, Huiling Mao & Chengyu Hu. (2022) Grass carp (Ctenopharyngodon idella) DYRK2 modulates cell apoptosis through phosphorylating p53. Fish & Shellfish Immunology 127, pages 542-548.
Crossref
Kai Yuan, Zhaoxing Li, Wenbin Kuang, Xiao Wang, Minghui Ji, Weijiao Chen, Jiayu Ding, Jiaxing Li, Wenjian Min, Chengliang Sun, Xiuquan Ye, Meiling Lu, Liping Wang, Haixia Ge, Yuzhang Jiang, Haiping Hao, Yibei Xiao & Peng Yang. (2022) Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer. Nature Communications 13:1.
Crossref
Amina Jamal Laham, Raafat El-Awady, Jean-Jacques Lebrun & Maha Saber Ayad. (2022) A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer. Cancers 14:8, pages 2034.
Crossref
Helin Atas-Ozcan, Véronique Brault, Arnaud Duchon & Yann Herault. (2021) Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes 12:11, pages 1833.
Crossref
Chia-Che Chang, Chien-Chih Chiu, Pei-Feng Liu, Chih-Hsuan Wu, Yen-Chiang Tseng, Cheng-Hsin Lee & Chih-Wen Shu. (2021) Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells. Cancers 13:22, pages 5779.
Crossref
Tomoyuki Furuya, Haruka Shinkawa, Masataka Kajikawa, Ryuichi Nishihama, Takayuki Kohchi, Hideya Fukuzawa & Hirokazu Tsukaya. (2021) A plant-specific DYRK kinase DYRKP coordinates cell morphology in Marchantia polymorpha. Journal of Plant Research 134:6, pages 1265-1277.
Crossref
Xiang Chen, Hongyu Xie, Xin Wang, Zhinan Zheng & Sanqing Jin. (2021) CIRBP Knockdown Attenuates Tumourigenesis and Improves the Chemosensitivity of Pancreatic Cancer via the Downregulation of DYRK1B. Frontiers in Cell and Developmental Biology 9.
Crossref
Florentin Pastor, Lulzim Shkreta, Benoit Chabot, David Durantel & Anna Salvetti. (2021) Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond. Frontiers in Microbiology 12.
Crossref
Nikolaos Kokkorakis & Maria Gaitanou. (2020) Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology. World Journal of Stem Cells 12:12, pages 1553-1575.
Crossref
Alejandro Correa-Sáez, Rafael Jiménez-Izquierdo, Martín Garrido-Rodríguez, Rosario Morrugares, Eduardo Muñoz & Marco A. Calzado. (2020) Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases. Cellular and Molecular Life Sciences 77:23, pages 4747-4763.
Crossref
Yannasittha Jiramongkol & Eric W.-F. Lam. (2020) FOXO transcription factor family in cancer and metastasis. Cancer and Metastasis Reviews 39:3, pages 681-709.
Crossref
Sang Bae Lee, Aram Ko, Young Taek Oh, Peiguo Shi, Fulvio D’Angelo, Brulinda Frangaj, Antonius Koller, Emily I. Chen, Timothy Cardozo, Antonio Iavarone & Anna Lasorella. (2020) Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation. Molecular Cell 79:3, pages 376-389.e8.
Crossref
Chao Dong, Kirk L. West, Xin Yi Tan, Junshi LiToyotaka IshibashiCheng-han Yu, Shirley M. H. Sy, Justin W. C. Leung & Michael S. Y. Huen. (2020) Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin. Proceedings of the National Academy of Sciences 117:29, pages 17019-17030.
Crossref
Hema Bye‐A‐Jee, Rossana Zaru, Michele Magrane & Sandra Orchard. (2020) Caenorhabditis elegans phosphatase complexes in UniProtKB and Complex Portal . The FEBS Journal 287:13, pages 2664-2684.
Crossref
Andrea I. Krahn, Carrow Wells, David H. Drewry, Lenore K. Beitel, Thomas M. Durcan & Alison D. Axtman. (2020) Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases. ACS Chemical Neuroscience 11:13, pages 1871-1886.
Crossref
Federica Prati, Rosa Buonfiglio, Guido Furlotti, Claudia Cavarischia, Giorgina Mangano, Rossella Picollo, Laura Oggianu, Anna di Matteo, Silvana Olivieri, Graziella Bovi, Pier Francesca Porceddu, Angelo Reggiani, Beatrice Garrone, Francesco Paolo Di Giorgio & Rosella Ombrato. (2020) Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model . ACS Medicinal Chemistry Letters 11:5, pages 825-831.
Crossref
Chun Shik Park, Andrew H. LewisTaylor J. ChenCory S. Bridges, Ye ShenKoramit SuppipatMonica Puppi, Julie A. TomolonisPaul D. PangToni-Ann Mistretta, Leyuan MaMichael R. GreenRachel Rau & H. Daniel Lacorazza. (2019) A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells. Blood 134:22, pages 1960-1972.
Crossref
Christian Lechner, Maren Flaßhoff, Hannes Falke, Lutz Preu, Nadége Loaëc, Laurent Meijer, Stefan Knapp, Apirat Chaikuad & Conrad Kunick. (2019) [b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors. Molecules 24:22, pages 4090.
Crossref
Jeroni Luna, Jacopo Boni, Miriam Cuatrecasas, Xavier Bofill-De Ros, Estela Núñez-Manchón, Meritxell Gironella, Eva C Vaquero, Maria L Arbones, Susana de la Luna & Cristina Fillat. (2019) DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. Gut 68:8, pages 1465-1476.
Crossref
Zaki Ahmad, Zoltán Magyar, László Bögre & Csaba Papdi. (2019) Cell cycle control by the target of rapamycin signalling pathway in plants. Journal of Experimental Botany 70:8, pages 2275-2284.
Crossref
Kazunori Sasaki, Julie Davies, Noelia Geribaldi Doldán, Sayo Arao, Farhana Ferdousi, Francis G. Szele & Hiroko Isoda. (2019) 3,4,5-Tricaffeoylquinic acid induces adult neurogenesis and improves deficit of learning and memory in aging model senescence-accelerated prone 8 mice. Aging 11:2, pages 401-422.
Crossref
Katie L. Uhl, Chad R. Schultz, Dirk Geerts & André S. Bachmann. (2018) Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma. Cancer Cell International 18:1.
Crossref
Walter Becker. (2017) A wake‐up call to quiescent cancer cells – potential use of DYRK 1B inhibitors in cancer therapy . The FEBS Journal 285:7, pages 1203-1211.
Crossref
Mohamed Salah, Mohammad Abdel-Halim & Matthias Engel. (2018) Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core. MedChemComm 9:6, pages 1045-1053.
Crossref
Solomon Tadesse, Ge Zhu, Laychiluh B Mekonnen, Jimma L Lenjisa, Mingfeng Yu, Michael P Brown & Shudong Wang. (2017) A novel series of N -(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors . Future Medicinal Chemistry 9:13, pages 1495-1506.
Crossref
Wen-Yu Huang, Yi-Chen Wu, Hsin-Yi Pu, Ying Wang, Geng-Jen Jang & Shu-Hsing Wu. (2017) Plant dual-specificity tyrosine phosphorylation-regulated kinase optimizes light-regulated growth and development in Arabidopsis . Plant, Cell & Environment 40:9, pages 1735-1747.
Crossref
Daisuke Ito, Satomi Yogosawa, Rei Mimoto, Shinichi Hirooka, Takashi Horiuchi, Ken Eto, Katsuhiko Yanaga & Kiyotsugu Yoshida. (2017) Dual‐specificity tyrosine‐regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer. Cancer Science 108:8, pages 1565-1573.
Crossref
Samira Abu Jhaisha, Esti W. Widowati, Isao Kii, Rie Sonamoto, Stefan Knapp, Chrisovalantis Papadopoulos & Walter Becker. (2017) DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain. Scientific Reports 7:1.
Crossref
Gabriella Castoria, Ferdinando Auricchio & Antimo Migliaccio. (2016) Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis. The FASEB Journal 31:4, pages 1289-1300.
Crossref
Xing Guo, Xiuliang Huang & Mark J. Chen. (2017) Reversible phosphorylation of the 26S proteasome. Protein & Cell 8:4, pages 255-272.
Crossref
Qingqing Zhou, Athena F. Phoa, Ramzi H. Abbassi, Monira Hoque, Tristan A. Reekie, Josep S. Font, Renae M. Ryan, Brett W. Stringer, Bryan W. Day, Terrance G. Johns, Lenka Munoz & Michael Kassiou. (2017) Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. Journal of Medicinal Chemistry 60:5, pages 2052-2070.
Crossref
Lu Cao, Yingzhi Tang, Zhenzhen Quan, Zhe Zhang, Stephen G. Oliver & Nianshu Zhang. (2016) Chronological Lifespan in Yeast Is Dependent on the Accumulation of Storage Carbohydrates Mediated by Yak1, Mck1 and Rim15 Kinases. PLOS Genetics 12:12, pages e1006458.
Crossref
Kate Keogh, David A. Kenny, Paul Cormican, Alan K. Kelly & Sinead M. Waters. (2016) Effect of dietary restriction and subsequent re-alimentation on the transcriptional profile of hepatic tissue in cattle. BMC Genomics 17:1.
Crossref
Apirat ChaikuadJulien Diharce, Martin Schröder, Alicia Foucourt, Bertrand Leblond, Anne-Sophie Casagrande, Laurent Désiré, Pascal Bonnet, Stefan Knapp & Thierry Besson. (2016) An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4- f ] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases . Journal of Medicinal Chemistry 59:22, pages 10315-10321.
Crossref
Christophe Labrière, Olivier Lozach, Mélina Blairvacq, Laurent Meijer & Catherine Guillou. (2016) Further investigation of Paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors. European Journal of Medicinal Chemistry 124, pages 920-934.
Crossref
Farrah Ali, Bilal Azhar Khan & Sarwat Sultana. (2016) Wedelolactone mitigates UVB induced oxidative stress, inflammation and early tumor promotion events in murine skin: plausible role of NFkB pathway. European Journal of Pharmacology 786, pages 253-264.
Crossref
Florian Glenewinkel, Michael J. Cohen, Cason R. King, Sophie Kaspar, Simone Bamberg-Lemper, Joe S. Mymryk & Walter Becker. (2016) The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2. Scientific Reports 6:1.
Crossref
Xiubing Zhang, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang, Shumin Lu, Li Liang, Jinxia Liu, Buyou Chen & Weidong Shi. (2016) Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma. Pathology - Research and Practice 212:3, pages 162-170.
Crossref
Wolfgang Gruber, Martin Hutzinger, Dominik Patrick Elmer, Thomas Parigger, Christina Sternberg, Lukasz Cegielkowski, Mirko Zaja, Johann Leban, Susanne Michel, Svetlana Hamm, Daniel Vitt & Fritz Aberger. (2016) DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance. Oncotarget 7:6, pages 7134-7148.
Crossref
Xing Guo, Xiaorong Wang, Zhiping Wang, Sourav Banerjee, Jing Yang, Lan Huang & Jack E. Dixon. (2015) Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nature Cell Biology 18:2, pages 202-212.
Crossref
Sang Bae Lee, Veronique Frattini, Mukesh Bansal, Angelica M. Castano, Dan Sherman, Keino Hutchinson, Jeffrey N. Bruce, Andrea Califano, Guangchao Liu, Timothy Cardozo, Antonio Iavarone & Anna Lasorella. (2016) An ID2-dependent mechanism for VHL inactivation in cancer. Nature 529:7585, pages 172-177.
Crossref
Mirja N. Shaikh, Francisco Gutierrez-Aviño, Jordi Colonques, Julian Ceron, Barbara Hämmerle & Francisco J. Tejedor. (2016) Minibrain drives the Dacapo dependent cell cycle exit of neurons in the Drosophila brain by promoting asense and prospero expression . Development.
Crossref
Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, Patrizia Dragone, Lucia Durando, Gabriele Magarò, Francesca Mancini, Giorgina Mangano, Rosella Ombrato, Marco Vitiello, Andrea Armirotti, Valeria Capurro, Massimiliano Lanfranco, Giuliana Ottonello, Maria Summa & Angelo Reggiani. (2015) Hit Optimization of 5-Substituted- N -(piperidin-4-ylmethyl)-1 H -indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders . Journal of Medicinal Chemistry 58:22, pages 8920-8937.
Crossref
M Fagerlind, H Stålhammar, B Olsson & K Klinga-Levan. (2015) Expression of miRNAs in Bull Spermatozoa Correlates with Fertility Rates. Reproduction in Domestic Animals 50:4, pages 587-594.
Crossref
Noriko Yamaguchi, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto & Kiyotsugu Yoshida. (2015) DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma. Tumor Biology 36:8, pages 5913-5923.
Crossref
Katharina Rüben, Anne Wurzlbauer, Agnes Walte, Wolfgang Sippl, Franz Bracher & Walter Becker. (2015) Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors. PLOS ONE 10:7, pages e0132453.
Crossref
Benjamin J. Thompson, Rahul Bhansali, Lauren Diebold, Daniel E. Cook, Lindsay Stolzenburg, Anne-Sophie Casagrande, Thierry Besson, Bertrand Leblond, Laurent Désiré, Sébastien Malinge & John D. Crispino. (2015) DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3. Journal of Experimental Medicine 212:6, pages 953-970.
Crossref
Ulf Soppa & Walter Becker. (2015) DYRK protein kinases. Current Biology 25:12, pages R488-R489.
Crossref
Liang-Nian Song, Jose Silva, Antonius Koller, Andrew Rosenthal, Emily I. Chen & Edward P. Gelmann. (2015) The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase. Molecular Cancer Research 13:5, pages 913-922.
Crossref
Yoshihiko Miyata. 2015. Protein Kinase CK2 Cellular Function in Normal and Disease States. Protein Kinase CK2 Cellular Function in Normal and Disease States 341 359 .
Pavel Karpov, Aleksey Raevsky, Maxim Korablyov & Yaroslav Blume. (2014) Identification of Plant Homologues of Dual Specificity Yak1-Related Kinases. Computational Biology Journal 2014, pages 1-14.
Crossref
G Castoria, P Giovannelli, M Di Donato, A Ciociola, R Hayashi, F Bernal, E Appella, F Auricchio & A Migliaccio. (2014) Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. Cell Death & Disease 5:12, pages e1548-e1548.
Crossref
Dawn deHaro, Kristine J. Kines, Mark Sokolowski, Robert T. Dauchy, Vincent A. Streva, Steven M. Hill, John P. Hanifin, George C. Brainard, David E. Blask & Victoria P. Belancio. (2014) Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night. Nucleic Acids Research 42:12, pages 7694-7707.
Crossref
Christian Schmitt, Dagmar Kail, Marica Mariano, Martin Empting, Nadja Weber, Tamara Paul, Rolf W. Hartmann & Matthias Engel. (2014) Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors. PLoS ONE 9:3, pages e87851.
Crossref
Dorothy M. Ryan, Thomas L. Vincent, Jacqueline Salit, Matthew S. Walters, Francisco Agosto-Perez, Renat Shaykhiev, Yael Strulovici-Barel, Robert J. Downey, Lauren J. Buro-Auriemma, Michelle R. Staudt, Neil R. Hackett, Jason G. Mezey & Ronald G. Crystal. (2014) Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD Risk Locus 19q13.2. PLoS ONE 9:2, pages e88051.
Crossref
N. Yang & A.M. Sheridan. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology 753 758 .
Nathan Luebbering, Mark Charlton-Perkins, Justin P. Kumar, Stephanie M. Rollmann, Tiffany Cook & Vaughn Cleghon. (2013) Drosophila Dyrk2 Plays a Role in the Development of the Visual System. PLoS ONE 8:10, pages e76775.
Crossref
Jia-Yun Chen, Jia-Ren Lin, Feng-Chiao Tsai & Tobias Meyer. (2013) Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle. Molecular Cell 52:1, pages 87-100.
Crossref
Guillaume Burgy, Tania Tahtouh, Emilie Durieu, Béatrice Foll-Josselin, Emmanuelle Limanton, Laurent Meijer, François Carreaux & Jean-Pierre Bazureau. (2013) Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines. European Journal of Medicinal Chemistry 62, pages 728-737.
Crossref
Eileen Friedman. (2013) Mirk/dyrk1B Kinase in Ovarian Cancer. International Journal of Molecular Sciences 14:3, pages 5560-5575.
Crossref